The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACADIA PHARMACEUTICALS INC COM 004225108   17,245,763 916,353 SH   SOLE   916,353 0 0
AFTERNEXT HEALTHTECH ACQUISITION CORP *W EXP 99/99/999 G01109126   61,087 366,666 SH   SOLE   366,666 0 0
AMICUS THERAPEUTICS INC COM 03152W109   16,193,341 1,460,175 SH   SOLE   1,460,175 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106   18,712,192 283,690 SH   SOLE   283,690 0 0
ARES ACQUISITION CORP *W EXP 02/02/202 G33032122   444,141 504,706 SH   SOLE   504,706 0 0
ARVINAS INC COM 04335A105   13,449,636 492,300 SH   SOLE   492,300 0 0
ASCENDIS PHARMA A/S SPONSORED ADR 04351P101   16,734,040 156,072 SH   SOLE   156,072 0 0
BILANDER ACQUISITION CORP *W EXP 05/19/202 09001T114   23,887 183,749 SH   SOLE   183,749 0 0
BRIDGETOWN HOLDINGS LTD *W EXP 09/30/202 G1355U121   134,429 895,000 SH   SOLE   895,000 0 0
CEREVEL THERAPEUTICS HLDNG I COM 15678U128   13,157,064 539,445 SH   SOLE   539,445 0 0
CHURCHILL CAPITAL CORP V *W EXP 10/29/202 17144T115   114,322 612,000 SH   SOLE   612,000 0 0
CHURCHILL CAPITAL CORP VI *W EXP 02/17/202 17143W119   59,400 540,000 SH   SOLE   540,000 0 0
CHURCHILL CAPITAL CORP VII *W EXP 02/29/202 17144M110   67,130 548,000 SH   SOLE   548,000 0 0
COMPASS DIGITAL ACQUISITION CORP *W EXP 09/29/202 G2476C123   59,834 459,906 SH   SOLE   459,906 0 0
CONCORD ACQUISITION CORP II *W EXP 99/99/999 20607U116   28,583 408,333 SH   SOLE   408,333 0 0
CONYERS PARK III ACQUISITION CORP *W EXP 08/12/202 21289P110   114,333 571,666 SH   SOLE   571,666 0 0
CORSAIR PARTNERING CORP *W EXP 07/06/202 G2540H116   53,580 334,666 SH   SOLE   334,666 0 0
CRINETICS PHARMACEUTICALS IN COM 22663K107   13,946,938 868,427 SH   SOLE   868,427 0 0
CYTOKINETICS INC COM NEW 23282W605   14,561,376 413,793 SH   SOLE   413,793 0 0
FIRST LIGHT ACQUISITION GROUP INC *W EXP 03/14/202 320703119   26,863 655,200 SH   SOLE   655,200 0 0
GALAPAGOS NV SPON ADR 36315X101   17,181,624 444,659 SH   SOLE   444,659 0 0
HOME PLATE ACQUISITION CORP *W EXP 09/30/202 43734R111   218,730 690,000 SH   SOLE   690,000 0 0
IVERIC BIO INC COM 46583P102   17,605,188 723,600 SH   SOLE   723,600 0 0
JAWS HURRICANE ACQUISITION CORP *W EXP 03/26/202 47201B111   60,062 387,249 SH   SOLE   387,249 0 0
MARBLEGATE ACQUISITION CORP *W EXP 08/31/202 56608A113   110,177 735,000 SH   SOLE   735,000 0 0
PROTHENA CORP PLC SHS G72800108   16,072,652 331,600 SH   SOLE   331,600 0 0
RELAY THERAPEUTICS INC COM 75943R102   13,938,067 846,270 SH   SOLE   846,270 0 0
ROSS ACQUISITION CORP II *W EXP 02/01/202 G7641C114   115,192 439,666 SH   SOLE   439,666 0 0
SAGE THERAPEUTICS INC COM 78667J108   16,316,775 388,865 SH   SOLE   388,865 0 0
SAREPTA THERAPEUTICS INC COM 803607100   16,919,597 122,757 SH   SOLE   122,757 0 0
SENIOR CONNECT ACQUISITION COR *W EXP 12/31/202 81723H116   51,308 1,014,000 SH   SOLE   1,014,000 0 0
SKYDECK ACQUISITION CORP *W EXP 05/13/202 G82220115   18,088 361,756 SH   SOLE   361,756 0 0
SOLID BIOSCIENCES INC COM NEW 83422E204   2,317,182 488,857 SH   SOLE   488,857 0 0
SPRINGWORKS THERAPEUTICS INC COM 85205L107   15,810,306 614,231 SH   SOLE   614,231 0 0
SWIFTMERGE ACQUISITION CORP *W EXP 12/13/202 G63836111   59,878 490,000 SH   SOLE   490,000 0 0
TRAVERE THERAPEUTICS INC COM 89422G107   19,683,720 875,221 SH   SOLE   875,221 0 0
YS BIOPHARMA CO LTD *W EXP 03/15/202 G9845F117   76,293 489,999 SH   SOLE   489,999 0 0
ZIMMER ENERGY TRANSITION ACQUISITION CORP *W EXP 06/16/202 989570114   60,118 358,270 SH   SOLE   358,270 0 0